Does the Italian reimbursement pathway allow for innovative drugs being highly priced, Dr. Stefano Capri and Dr. Entela Xoxi?

Venture into the heart of Italy’s healthcare system with Dr. Stefan Walzer and two Italian experts, Prof. Dr. Stefano Capri and Dr. Entela Xoxi, as they unravel the complexities of the Italian reimbursement landscape. This episode takes you behind the scenes of Italy’s innovation pathway, exploring what this evolution means for the pharmaceutical industry and health care accessibility. Is negotiating a premium price for new treatments as straightforward as it seems? Join us for an enlightening discussion that sheds light on these questions and more. Don’t miss out on the opportunity to deepen your understanding of global market access strategies. Subscribe now on your favorite podcast platform or listen directly on our website. Stay ahead of the curve with MArS, your go-to bi-weekly podcast for exclusive insights into market access and pricing strategies.

Listen to the podcast: here